These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37676602)

  • 1. Recent Deep Learning Applications to Structure-Based Drug Design.
    Verburgt J; Jain A; Kihara D
    Methods Mol Biol; 2024; 2714():215-234. PubMed ID: 37676602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generative Deep Learning for Targeted Compound Design.
    Sousa T; Correia J; Pereira V; Rocha M
    J Chem Inf Model; 2021 Nov; 61(11):5343-5361. PubMed ID: 34699719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geometric deep learning methods and applications in 3D structure-based drug design.
    Bai Q; Xu T; Huang J; Pérez-Sánchez H
    Drug Discov Today; 2024 Jul; 29(7):104024. PubMed ID: 38759948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The power of deep learning to ligand-based novel drug discovery.
    Baskin II
    Expert Opin Drug Discov; 2020 Jul; 15(7):755-764. PubMed ID: 32228116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modern machine learning for tackling inverse problems in chemistry: molecular design to realization.
    Sridharan B; Goel M; Priyakumar UD
    Chem Commun (Camb); 2022 Apr; 58(35):5316-5331. PubMed ID: 35416193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep learning for molecular generation.
    Xu Y; Lin K; Wang S; Wang L; Cai C; Song C; Lai L; Pei J
    Future Med Chem; 2019 Mar; 11(6):567-597. PubMed ID: 30698019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HydraScreen: A Generalizable Structure-Based Deep Learning Approach to Drug Discovery.
    Prat A; Abdel Aty H; Bastas O; Kamuntavičius G; Paquet T; Norvaišas P; Gasparotto P; Tal R
    J Chem Inf Model; 2024 Aug; 64(15):5817-5831. PubMed ID: 39037942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fully differentiable ligand pose optimization framework guided by deep learning and a traditional scoring function.
    Wang Z; Zheng L; Wang S; Lin M; Wang Z; Kong AW; Mu Y; Wei Y; Li W
    Brief Bioinform; 2023 Jan; 24(1):. PubMed ID: 36502369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating QSAR modelling and deep learning in drug discovery: the emergence of deep QSAR.
    Tropsha A; Isayev O; Varnek A; Schneider G; Cherkasov A
    Nat Rev Drug Discov; 2024 Feb; 23(2):141-155. PubMed ID: 38066301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep Learning in Structure-Based Drug Design.
    Anighoro A
    Methods Mol Biol; 2022; 2390():261-271. PubMed ID: 34731473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MedGAN: optimized generative adversarial network with graph convolutional networks for novel molecule design.
    Macedo B; Ribeiro Vaz I; Taveira Gomes T
    Sci Rep; 2024 Jan; 14(1):1212. PubMed ID: 38216614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De Novo Peptide and Protein Design Using Generative Adversarial Networks: An Update.
    Lin E; Lin CH; Lane HY
    J Chem Inf Model; 2022 Feb; 62(4):761-774. PubMed ID: 35128926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAGAN: An approach for improve the stability of molecular graph generation based on generative adversarial networks.
    Zou J; Yu J; Hu P; Zhao L; Shi S
    Comput Biol Med; 2023 Dec; 167():107691. PubMed ID: 37976819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNMG: Deep molecular generative model by fusion of 3D information for de novo drug design.
    Song T; Ren Y; Wang S; Han P; Wang L; Li X; Rodriguez-Patón A
    Methods; 2023 Mar; 211():10-22. PubMed ID: 36764588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based drug design with geometric deep learning.
    Isert C; Atz K; Schneider G
    Curr Opin Struct Biol; 2023 Apr; 79():102548. PubMed ID: 36842415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving drug discovery with a hybrid deep generative model using reinforcement learning trained on a Bayesian docking approximation.
    Xiong Y; Wang Y; Wang Y; Li C; Yusong P; Wu J; Wang Y; Gu L; Butch CJ
    J Comput Aided Mol Des; 2023 Nov; 37(11):507-517. PubMed ID: 37550462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Logistic matrix factorisation and generative adversarial neural network-based method for predicting drug-target interactions.
    Abbou SI; Bouziane H; Chouarfia A
    Mol Divers; 2021 Aug; 25(3):1497-1516. PubMed ID: 34297278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of protein-ligand binding affinity via deep learning models.
    Wang H
    Brief Bioinform; 2024 Jan; 25(2):. PubMed ID: 38446737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Training recurrent neural networks as generative neural networks for molecular structures: how does it impact drug discovery?
    D'Souza S; Kv P; Balaji S
    Expert Opin Drug Discov; 2022 Oct; 17(10):1071-1079. PubMed ID: 36216812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computer-Aided Drug Discovery and Design: Recent Advances and Future Prospects.
    Talevi A
    Methods Mol Biol; 2024; 2714():1-20. PubMed ID: 37676590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.